| Value | ₹0.07 Cr |
|---|
NSE filing, NSE: INDOSTAR. Summary written from the filing by ALFA Finder's alert engine.
Indostar Capital Finance Ltd: key numbers
- Share price
- ₹193.34
- Market cap
- ₹3,126 Cr
- Revenue (annual)
- ₹1,393 Cr
- Net profit (annual)
- ₹140.4 Cr
- P/E (TTM)
- -7.9×Sector 19.7×
- Promoter holding
- 70.33%-0.03% QoQ
- FII holding
- 2.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indostar Capital Finance Ltd
All →Indostar Capital Finance Board Meeting Date
IndoStar Capital Finance has scheduled a board meeting on October 29, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Indostar Capital Finance Other Announcement
Indostar Capital Finance Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026. This is a mandatory compliance disclosure under SEBI regulations.
Indostar Capital Finance Other Announcement
IndoStar Capital Finance Limited submitted the quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, received from its Registrar, MUFG Intime.
Indostar Capital Finance Other Announcement
Dipesh Jagdish Mehta, categorized as 'Other', sold 2,800 equity shares of Indostar Capital Finance Ltd worth Rs.5.92 Lakhs via market sale.
- Value
- ₹0.06 Cr
Indostar Capital Finance Other Announcement
Dipesh Jagdish Mehta sold Indostar Capital Finance shares in the open market. This disclosure is a routine PIT Regulation 7(2) insider trade filing.
- Value
- ₹1.33 Cr
Indostar Capital Finance Debt & Borrowing: ₹25 Cr
IndoStar Capital Finance has successfully redeemed its Non-Convertible Debentures (NCDs), paying out the principal amount of ₹25 Crore on the maturity date.
- Value
- ₹25.00 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.